Peer-influenced content. Sources you trust. No registration required. This is HCN.
Facty Health
Provide your patients with this checklist of more than a dozen foods to help them lower their cholesterol. From almonds to orange juice, avocadoes to soy, the nutritional weapons against heart disease, stroke, and other ailments is vast.
Cardiology November 16th 2021
Healthgrades for Professionals
More than half of adult Americans (60%) have at least one chronic condition that eventually lead to disability, mortality, and reduced quality of life. And chronic conditions account for 90% of America’s $3.8 trillion in annual healthcare costs. The CDC says these are the eight most expensive.
Cardiology October 29th 2021
Our understanding of lipid pathology is shifting from what might be called the “LDL hypothesis” to the “atherogenic lipoprotein hypothesis.” LDL is just a surrogate of the actual process of lipoprotein interaction with the arterial wall. This shift in understanding is driving a host of budding therapies with novel approaches to targeting key atherogenesis players like lipoprotein(a) and triglycerides.
Cardiology October 5th 2021
Research shows that the “old” 2015 recommendation would only identify about half of Americans with prediabetes and undiagnosed type 2 diabetes. Based on this data, the US Preventive Services Task Force has lowered the recommended screening age from 40 to 35 years in asymptomatic, nonpregnant adults who are overweight or obese.
Endocrinology, Diabetes, Metabolism August 31st 2021
Pediatric B-cell acute lymphoblastic leukemia (B-ALL) is the most common malignancy seen in children and adolescents and young adults (AYAs). This article highlights two recent studies that provide novel evidence of the association between obesity and increased risk of high-risk B-ALL and the effectiveness of a non-pharmacologic intervention for reducing minimal residual disease (MRD) risk.
Endocrinology, Diabetes, Metabolism June 28th 2021
Journal of Clinical Oncology
An update from the original ASCO guideline on this topic published in 2012, 60 studies, primarily retrospective, were included in the review. New to this version of the guideline, the Panel offers recommendations on approved doses of immunotherapy and targeted therapies that can be offered to obese patients with cancer.
Endocrinology, Diabetes, Metabolism June 21st 2021